Patents by Inventor Des Richardson

Des Richardson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemotherapy for Drug-Resistant Cancer Cells
    Publication number: 20150306081
    Abstract: The present invention relates to new treatments of multidrug resistant disorders, particularly cancers. There is provided a method of treating a cancer including administering an effective amount of a semicarbazone or hydrazone compound to a patient that has cancer, the cancer including a cancerous cell that includes an active efflux mechanism; wherein the compound is a substrate of the active efflux mechanism and the compound is able to form a chelation complex with a metal species in the cancerous cell, the chelation complex being cytotoxic to the cancerous cell.
    Type: Application
    Filed: November 22, 2013
    Publication date: October 29, 2015
    Applicant: ONCOCHEL THERAPEUTICS LLC
    Inventors: Des Richardson, Patric Jansson, Tetsuo Yamagishi
  • Iron chelators and uses thereof
    Patent number: 6989397
    Abstract: The present invention provides 2-pyridylcarboxaldehyde isonicotinoyl hydrazone (PCIH) analogues suitable for use as an in vivo iron chelators, the PCIH analogue having Formula 1: wherein R1 is an aromatic or heterocyclic group and R2 is either H or OH; isomers thereof or salts thereof; pharmaceutical compositions containing the analogues; and uses of the analogues in the treatment of iron-overload diseases.
    Type: Grant
    Filed: September 4, 2000
    Date of Patent: January 24, 2006
    Assignees: University of Queensland, The Heart Research Institute Ltd.
    Inventors: Des Richardson, Paul Vincent Bernhardt, Erika Michelle Becker